<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.napwa.org.au" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>clinical trials</title>
 <link>http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials</link>
 <description>Customised to include nested data</description>
 <language>en-au</language>
<item>
 <title>Clinical Trials</title>
 <link>http://www.napwa.org.au/resource/clinical-trials</link>
 <description> &lt;p&gt;This fact sheet provides you with information and some questions to ask if you are considering participating in a &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/89&quot;&gt;&lt;span&gt;clinical trial&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. &lt;/span&gt;.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/resource/clinical-trials&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/clinical-trials-database-background-information">Clinical trials database background information</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/813">NAPWA member organisations&amp;#039; fact sheets</category>
 <enclosure url="http://www.napwa.org.au/files/7_ClinicalTrials_0.pdf" length="123653" type="application/pdf" />
 <enclosure url="http://www.napwa.org.au/image/view/1716/preview" length="11876" type="image/jpeg" />
 <pubDate>Wed, 30 Jun 2004 07:00:00 -0700</pubDate>
 <dc:creator />
 <guid isPermaLink="false">1717 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>New trial needs volunteers</title>
 <link>http://www.napwa.org.au/pl/2011/12/new-trial-needs-volunteers</link>
 <description> &lt;p&gt;At the conference, Julian Elliot from The Burnet Institute in Melbourne spoke of our ‘combo-prevention future’, where a successful vaccine and cure could potentially end the epidemic.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2011/12/new-trial-needs-volunteers&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/defeating-hiv">Defeating HIV</category>
 <category domain="http://www.napwa.org.au/defeating-hiv/hiv-research/clinical-research">clinical research</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <pubDate>Wed, 23 Nov 2011 20:08:39 -0800</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">2821 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Rilpivirine as good as efavirenz</title>
 <link>http://www.napwa.org.au/pl/2011/12/rilpivirine-as-good-as-efavirenz</link>
 <description> &lt;p&gt;Dr Mark Bloch from Holdsworth House in Sydney presented the 48-week results of the combined ECHO and THRIVE studies which determined that the new NNRTI rilpivirine (RPV) is as effective as efavirenz (EFV) for first-line treatment.&lt;/p&gt;
&lt;p&gt;Everyone in the studies received a nucleoside backbone to their treatment – in ECHO it was Truvada, in THRIVE it was tenfovir/3TC or abacavir/3TC.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2011/12/rilpivirine-as-good-as-efavirenz&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nnrtis/efavirenz">efavirenz</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <pubDate>Wed, 23 Nov 2011 19:54:17 -0800</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">2819 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Consumer Guide to Clinical Trials released</title>
 <link>http://www.napwa.org.au/2011/09/15/consumer-guide-to-clinical-trials-released</link>
 <description> &lt;p&gt;The Clinical Trials Action Group (CTAG) was established in October 2009 to identify and progress necessary reforms to secure Australia’s competitiveness in the &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/475&quot;&gt;&lt;span&gt;clinical&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;Pertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science.&lt;/span&gt; trials sector. &lt;/p&gt;
&lt;p&gt;Following the release of the CTAG&#039;s report, the Consumers Health Forum was funded by the Department of Innovation, Industry, Science and Research to develop a factsheet to provide consumer-friendly information about clinical trials, in response to a recommendation for improved consumer access to information on clinical trials.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/2011/09/15/consumer-guide-to-clinical-trials-released&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/265">news</category>
 <enclosure url="http://www.napwa.org.au/files/CHF Clinical Trials Factsheet.pdf" length="133480" type="application/pdf" />
 <enclosure url="http://www.napwa.org.au/image/view/2769/preview" length="19537" type="image/jpeg" />
 <pubDate>Wed, 14 Sep 2011 20:56:44 -0700</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">2768 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>The START Trial: information for prospective participants</title>
 <link>http://www.napwa.org.au/the-start-trial-information-for-prospective-participants</link>
 <description> &lt;p&gt;Information about the START trial, which is seeking to establish the best time to start HIV treatment.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/the-start-trial-information-for-prospective-participants&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/taxonomy/term/812">Other fact sheets</category>
 <category domain="http://www.napwa.org.au/treating-hiv/understanding-hiv-treatments/starting-treatments">starting treatments</category>
 <enclosure url="http://www.napwa.org.au/files/START_Participant Brochure.pdf" length="100180" type="application/pdf" />
 <enclosure url="http://www.napwa.org.au/image/view/2256/preview" length="3235" type="image/gif" />
 <pubDate>Thu, 20 May 2010 17:04:49 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">2257 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Clinical Trial Action Group Public Submissions</title>
 <link>http://www.napwa.org.au/papers/2010/clinical-trial-action-group-public-submissions</link>
 <description> &lt;p&gt;NAPWA recently contributed to the &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/89&quot;&gt;&lt;span&gt;Clinical Trial&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. &lt;/span&gt; Action Group.  NAPWA has been closely engaged in &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/475&quot;&gt;&lt;span&gt;clinical&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;Pertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science.&lt;/span&gt; trials involving &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/689&quot;&gt;&lt;span&gt;PLHIV&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;Person (or people) Living with HIV. This term is now preferred over the older PLWHA.&lt;/span&gt; throughout its history.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/papers/2010/clinical-trial-action-group-public-submissions&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv">Treating HIV</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/clinical-trials-database-background-information">Clinical trials database background information</category>
 <category domain="http://www.napwa.org.au/projects/health-treatments-and-research">Health, Treatments and Research</category>
 <category domain="http://www.napwa.org.au/papers/submission">submission</category>
 <enclosure url="http://www.napwa.org.au/files/NAPWA CT submission _2_.pdf" length="424909" type="application/pdf" />
 <enclosure url="http://www.napwa.org.au/image/view/834/preview" length="15999" type="image/jpeg" />
 <pubDate>Thu, 11 Mar 2010 14:44:26 -0800</pubDate>
 <dc:creator>Scott Lockhart</dc:creator>
 <guid isPermaLink="false">2179 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Lower dosing trial funded</title>
 <link>http://www.napwa.org.au/pl/2009/06/lower-dosing-trial-funded</link>
 <description> &lt;p&gt;The Bill and Melinda Gates Foundation has granted AUD $12.4 million to the University of NSW to study whether lower doses of some commonly used &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/122&quot;&gt;&lt;span&gt;antiretroviral&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A medication or other substance which is active against retroviruses such as HIV.&lt;/span&gt; drugs are as effective as currently prescribed doses.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2009/06/lower-dosing-trial-funded&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/defeating-hiv/hiv-research/clinical-research">clinical research</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nnrtis/efavirenz">efavirenz</category>
 <category domain="http://www.napwa.org.au/defeating-hiv/the-global-hiv-epidemic">The global HIV epidemic</category>
 <enclosure url="http://www.napwa.org.au/image/view/1580/preview" length="20794" type="image/jpeg" />
 <pubDate>Thu, 04 Jun 2009 22:22:46 -0700</pubDate>
 <dc:creator>Jill Sergeant</dc:creator>
 <guid isPermaLink="false">1581 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Trial begins for HIV gene therapy</title>
 <link>http://www.napwa.org.au/pl/2009/03/trial-begins-for-hiv-gene-therapy</link>
 <description> &lt;p&gt;&lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/126&quot;&gt;&lt;span&gt;Gene&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;The most basic unit of genetic information.&lt;/span&gt; therapy that could immunise people against the most common type of HIV is ready to be tested on humans.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2009/03/trial-begins-for-hiv-gene-therapy&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <enclosure url="http://www.napwa.org.au/image/view/1113/preview" length="22229" type="image/jpeg" />
 <pubDate>Thu, 12 Mar 2009 17:02:49 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">1114 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Clinical trials</title>
 <link>http://www.napwa.org.au/resource/next-steps/clinical-trials</link>
 <description> &lt;p&gt;Clinical trials are used to test the safety and effects of new drugs, combinations of drugs, and/or drug dosing strategies.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/resource/next-steps/clinical-trials&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <pubDate>Sun, 30 Nov 2008 06:00:00 -0800</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">996 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>AIDS 2008: Is the HIV drug pipeline drying up?</title>
 <link>http://www.napwa.org.au/pl/2008/09/aids-2008-is-the-hiv-drug-pipeline-drying-up</link>
 <description> &lt;p&gt;The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-&lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/109&quot;&gt;&lt;span&gt;resistant&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;HIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.&lt;/span&gt; HIV, all of which are now available in Australia.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2008/09/aids-2008-is-the-hiv-drug-pipeline-drying-up&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/clinical-trials">clinical trials</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatment-0">elvitegravir (GS-9137)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/etravirine-t">etravirine (TMC-125)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/experimental-treatments/attachment-inhibitor">maraviroc</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/nnrtis/experimental-treatments/rilpivirine-">rilpivirine (TMC 278)</category>
 <enclosure url="http://www.napwa.org.au/image/view/868/preview" length="16012" type="image/jpeg" />
 <pubDate>Tue, 23 Sep 2008 19:21:56 -0700</pubDate>
 <dc:creator>David Menadue</dc:creator>
 <guid isPermaLink="false">869 at http://www.napwa.org.au</guid>
</item>
</channel>
</rss>

